首页> 外文会议>American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics >Identification of disulfide-bridges in human serum proteins using mass spectrometry and concatenated peptide databases
【24h】

Identification of disulfide-bridges in human serum proteins using mass spectrometry and concatenated peptide databases

机译:用质谱和串联肽数据库鉴定人血清蛋白中二硫桥

获取原文

摘要

A workflow for detection of endogenous disulfide-linked peptides was presented. Previously published and unpublished disulfide bridged peptides were detected; this may be due to the generation of disulfide rearrangements during sample preparation or heterogeneity of the serum. By annotation of the fragment ions observed in both the forward and reversed concatenated sequences, full sequence coverage and exact location of the disulfide bridge residues was achieved. Analysis by HCD allowed for more fragmentation and gave better utility for determination of disulfide localization than CID. ETD using a target list from the CID runs did not allow for the detection of all of the disulfide bridged peptides nor did it show any clear advantage over the peptides determined by either CID or HCD. However, the use of a target list based on CID/HCD identifications does not necessarily include the peptides best suited for ETD fragmentation.
机译:提出了一种检测内源二硫键连接肽的工作流程。以前出版和未发表的二硫化二硫化物桥肽被检测到;这可能是由于在样品制备或血清的异质性期间产生二硫键重排。通过向前和反相级联序列中观察到的片段离子的注释,实现了二硫化物桥残基的全序列覆盖和精确位置。通过HCd分析允许更多的碎片化,并提供比CID的二硫键定位的更好的效用。使用来自CID的目标列表的ETD不允许检测所有二硫化物桥接肽,也不表现出通过CID或HCd测定的肽的任何明显的优势。然而,基于CID / HCD鉴定的目标列表不一定包括最适合于ETD碎片的肽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号